Cessation of Antimalarial Agents Feasible in Patients With Quiescent SLE - Rheumatology Advisor

Researchers evaluated the rate of flare in patients with systemic lupus erythematosus who withdrew from antimalarial medications (AM) after achieving disease remission.

The cessation of antimalarial medications was shown to be feasible with a slow taper in patients with systemic lupus erythematosus (SLE) with disease quiescence, according to study results published … [+4069 chars]

full article...